Unmasking Early-Onset Gastric Cancer in a Low-Incidence Setting: Insights from Eritrea National Health Laboratory 11-year study

preprint OA: closed
Full text JSON View at publisher
Full text 17,667 characters · extracted from preprint-html · click to expand
Unmasking Early-Onset Gastric Cancer in a Low-Incidence Setting: Insights from Eritrea National Health Laboratory 11-year study | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Unmasking Early-Onset Gastric Cancer in a Low-Incidence Setting: Insights from Eritrea National Health Laboratory 11-year study Samuel Tekle Mengistu, Meron Tesfay, Yafet Kesete, Genet Tekeste Fikadu, and 7 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7632634/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Introduction Gastric cancer (GC) remains a major global health concern, ranking among the leading causes of cancer-related morbidity and mortality, with over one million new cases and hundreds of thousands of deaths annually. While incidence and mortality are declining in high-income countries, the burden has shifted toward low- and middle-income countries, which now account for the majority of GC-related deaths. Sub-Saharan Africa is traditionally considered a low-incidence region, yet the paradox of a high prevalence of Helicobacter pylori alongside comparatively low GC rates, the so-called “African Enigma”, remains poorly understood, partly due to limitations in cancer data collection. In Eritrea, where robust data are scarce, the epidemiology of GC has not been systematically studied, highlighting the need for population-based evidence to clarify incidence, trends, and associated risk factors. Method We conducted a retrospective audit of gastric biopsy cases processed at the National Health Laboratory (NHL), the only diagnostic pathology center in Eritrea, between January 2011 and December 2021. All Eritrean patients who underwent endoscopic-guided gastric biopsy during this period were included, while non-Eritrean patients and records with missing outcome data were excluded. Demographic and clinical information was extracted from laboratory records, including age, sex, residence, and histopathological subtype. Data were analyzed using SPSS and R, with descriptive statistics, chi-square tests, Fisher’s exact test, and non-parametric comparisons as appropriate. Crude incidence rates (CIR), age-standardized incidence rates (ASIR), and estimated annual percentage change (EAPC) were calculated. Trends were assessed using Joinpoint regression, and logistic regression was applied to evaluate associations between risk factors and gastric cancer. Results Among 6,496 gastric biopsy samples processed from 2011 to 2021, 226 (3.6%) were gastroduodenoscopy specimens, of which 101 (44.6%) were malignant. Median age was higher for malignant cases (57 years) compared to non-malignant cases (47 years), while gender distribution was similar. Late-onset gastric cancer (> 50 years) accounted for 63% of malignant cases. Adenocarcinoma was the predominant histological subtype, peaking in older age groups, whereas lymphoma and squamous cell carcinoma showed distinct age and gender patterns. Crude incidence rates (CIR) and age-standardized rates (ASR) demonstrated temporal variability, with peak ASR in 2021 (1.535 per 100,000) and a male-to-female ratio of 1.27:1 overall. Regional analysis indicated higher case clustering in the Maekel zone, particularly around Asmara. Multivariate regression identified age as an independent risk factor for malignancy (OR = 1.04 per year), while sex and geographic region were not significantly associated. Conclusion Gastric cancer in Eritrea reflects global age and sex patterns but shows a relatively high proportion of early-onset cases and distinctive histological trends in women. Combined with high H. pylori prevalence, an aging population, and limited diagnostic capacity, these findings indicate a likely increase in gastric cancer burden. Strengthening surveillance, prevention, and equitable diagnostic access is essential to address this emerging challenge. Clinical trial number : not applicable. Gastric cancer Eritrea incidence early-onset histological subtype age-standardized rate H. pylori epidemiology biopsy population-based study Full Text Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7632634","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":520400760,"identity":"51d95a5d-eef1-45f7-b0ec-edc427681969","order_by":0,"name":"Samuel Tekle Mengistu","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA20lEQVRIiWNgGAWjYFACNsYDIMr+eAOQNLAgrIGHgY0BrIXhDIgykCBFy40EEEmEFnv2toQDH/7YRTPOfH51w48CCQb+9u4E/LbwHDtwcGZbcm6zdE7ZzR6gwyTOnN2AX4tEesNh3gbm3DbpnLQbPEAtBhK5BLTIP284/OdPfW6P5Jm0m3+I0iLBduAwA9vh3BkS7MduE2fLmbSEg71tx3M38OSw3ZYxkOAh6Bf29mOGD378qc7dwH782c03f2zk+Nt78WtBttAATBKrHGzhA1JUj4JRMApGwQgCAJBcS2kX7p9iAAAAAElFTkSuQmCC","orcid":"","institution":"Nakfa Hospital, Ministry of health Northern Red Sea branch","correspondingAuthor":true,"prefix":"","firstName":"Samuel","middleName":"Tekle","lastName":"Mengistu","suffix":""},{"id":520400761,"identity":"ffb15774-bfca-4fac-b5fd-8de5f742b75f","order_by":1,"name":"Meron Tesfay","email":"","orcid":"","institution":"Nakfa Hospital, Ministry of health Northern Red Sea branch","correspondingAuthor":false,"prefix":"","firstName":"Meron","middleName":"","lastName":"Tesfay","suffix":""},{"id":520400762,"identity":"e7c38a9e-4bd3-4d1b-91e7-9d1482b07b94","order_by":2,"name":"Yafet Kesete","email":"","orcid":"","institution":"Nakfa Hospital, Ministry of health Northern Red Sea branch","correspondingAuthor":false,"prefix":"","firstName":"Yafet","middleName":"","lastName":"Kesete","suffix":""},{"id":520400763,"identity":"66a99a49-0633-47bb-b12d-4d5abcdbd9f2","order_by":3,"name":"Genet Tekeste Fikadu","email":"","orcid":"","institution":"Department of Pathology, National Health Laboratory, Ministry of Health","correspondingAuthor":false,"prefix":"","firstName":"Genet","middleName":"Tekeste","lastName":"Fikadu","suffix":""},{"id":520400764,"identity":"ea681fe0-56eb-4747-b579-7eaa7cf57167","order_by":4,"name":"Henok Afewerki Kidane","email":"","orcid":"","institution":"The Guardian Group","correspondingAuthor":false,"prefix":"","firstName":"Henok","middleName":"Afewerki","lastName":"Kidane","suffix":""},{"id":520400765,"identity":"da157bf2-b951-425d-804c-8824dda9e5b5","order_by":5,"name":"Yonas Tesfagabr Abraham","email":"","orcid":"","institution":"University of California, Davis","correspondingAuthor":false,"prefix":"","firstName":"Yonas","middleName":"Tesfagabr","lastName":"Abraham","suffix":""},{"id":520400766,"identity":"1dd5c2de-ae46-4023-b614-2de38455fea3","order_by":6,"name":"Robel Afeworki Habte","email":"","orcid":"","institution":"African Community Health Institute","correspondingAuthor":false,"prefix":"","firstName":"Robel","middleName":"Afeworki","lastName":"Habte","suffix":""},{"id":520400767,"identity":"e437d671-53c8-4ab1-b351-98764f69ed9b","order_by":7,"name":"Eseyas Semere Tsehaye","email":"","orcid":"","institution":"American University of Antigua College of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Eseyas","middleName":"Semere","lastName":"Tsehaye","suffix":""},{"id":520400768,"identity":"892e3025-b5a9-4638-bbd6-e4bebb91d88c","order_by":8,"name":"Salih Mohammed Said","email":"","orcid":"","institution":"Ministry of Health","correspondingAuthor":false,"prefix":"","firstName":"Salih","middleName":"Mohammed","lastName":"Said","suffix":""},{"id":520400769,"identity":"8ed29b7d-5d13-4460-9085-22ced3b77f4e","order_by":9,"name":"Yosief Tewolde Ghidei","email":"","orcid":"","institution":"Orotta College of Medicine and Health Sciences","correspondingAuthor":false,"prefix":"","firstName":"Yosief","middleName":"Tewolde","lastName":"Ghidei","suffix":""},{"id":520400770,"identity":"31f10d36-132b-4cc4-8d9c-c69fe1a89529","order_by":10,"name":"Negassi Leake","email":"","orcid":"","institution":"Orotta College of Medicine and Health Sciences","correspondingAuthor":false,"prefix":"","firstName":"Negassi","middleName":"","lastName":"Leake","suffix":""}],"badges":[],"createdAt":"2025-09-16 16:38:24","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7632634/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7632634/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":92249114,"identity":"d2a402f0-fa95-4781-992c-bb0e7e1b2f4d","added_by":"auto","created_at":"2025-09-26 10:14:37","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1388625,"visible":true,"origin":"","legend":"","description":"","filename":"GastricCancerEpidemiologyinEritreaV1.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7632634/v1_covered_1fbf08b0-7380-4b8b-803c-6ac507a57bb5.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Unmasking Early-Onset Gastric Cancer in a Low-Incidence Setting: Insights from Eritrea National Health Laboratory 11-year study","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Gastric cancer, Eritrea, incidence, early-onset, histological subtype, age-standardized rate, H. pylori, epidemiology, biopsy, population-based study","lastPublishedDoi":"10.21203/rs.3.rs-7632634/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7632634/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eIntroduction\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eGastric cancer (GC) remains a major global health concern, ranking among the leading causes of cancer-related morbidity and mortality, with over one million new cases and hundreds of thousands of deaths annually. While incidence and mortality are declining in high-income countries, the burden has shifted toward low- and middle-income countries, which now account for the majority of GC-related deaths. Sub-Saharan Africa is traditionally considered a low-incidence region, yet the paradox of a high prevalence of \u003cem\u003eHelicobacter pylori\u003c/em\u003e alongside comparatively low GC rates, the so-called “African Enigma”, remains poorly understood, partly due to limitations in cancer data collection. In Eritrea, where robust data are scarce, the epidemiology of GC has not been systematically studied, highlighting the need for population-based evidence to clarify incidence, trends, and associated risk factors.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethod\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe conducted a retrospective audit of gastric biopsy cases processed at the National Health Laboratory (NHL), the only diagnostic pathology center in Eritrea, between January 2011 and December 2021. All Eritrean patients who underwent endoscopic-guided gastric biopsy during this period were included, while non-Eritrean patients and records with missing outcome data were excluded. Demographic and clinical information was extracted from laboratory records, including age, sex, residence, and histopathological subtype. Data were analyzed using SPSS and R, with descriptive statistics, chi-square tests, Fisher’s exact test, and non-parametric comparisons as appropriate. Crude incidence rates (CIR), age-standardized incidence rates (ASIR), and estimated annual percentage change (EAPC) were calculated. Trends were assessed using Joinpoint regression, and logistic regression was applied to evaluate associations between risk factors and gastric cancer.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAmong 6,496 gastric biopsy samples processed from 2011 to 2021, 226 (3.6%) were gastroduodenoscopy specimens, of which 101 (44.6%) were malignant. Median age was higher for malignant cases (57 years) compared to non-malignant cases (47 years), while gender distribution was similar. Late-onset gastric cancer (\u0026gt; 50 years) accounted for 63% of malignant cases. Adenocarcinoma was the predominant histological subtype, peaking in older age groups, whereas lymphoma and squamous cell carcinoma showed distinct age and gender patterns. Crude incidence rates (CIR) and age-standardized rates (ASR) demonstrated temporal variability, with peak ASR in 2021 (1.535 per 100,000) and a male-to-female ratio of 1.27:1 overall. Regional analysis indicated higher case clustering in the Maekel zone, particularly around Asmara. Multivariate regression identified age as an independent risk factor for malignancy (OR = 1.04 per year), while sex and geographic region were not significantly associated.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eGastric cancer in Eritrea reflects global age and sex patterns but shows a relatively high proportion of early-onset cases and distinctive histological trends in women. Combined with high H. pylori prevalence, an aging population, and limited diagnostic capacity, these findings indicate a likely increase in gastric cancer burden. Strengthening surveillance, prevention, and equitable diagnostic access is essential to address this emerging challenge.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eClinical trial number\u003c/strong\u003e: not applicable.\u003c/p\u003e","manuscriptTitle":"Unmasking Early-Onset Gastric Cancer in a Low-Incidence Setting: Insights from Eritrea National Health Laboratory 11-year study","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-09-26 10:06:29","doi":"10.21203/rs.3.rs-7632634/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"c471422d-aad8-4704-b330-91f407680bc1","owner":[],"postedDate":"September 26th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2025-09-26T10:06:29+00:00","versionOfRecord":[],"versionCreatedAt":"2025-09-26 10:06:29","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7632634","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7632634","identity":"rs-7632634","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00